Objective. Indicators of work role functioning (being at work, and being productive while at
work) are important outcomes for persons with arthritis. As the worker productivity working …

Cancer and viruses have a long history that has evolved over many decades. Much information
about the interplay between viruses and cell proliferation and metabolism has come from …

Objectives To assess the efficacy and safety of certolizumab pegol (CZP)+dose-optimised
methotrexate (MTX) versus placebo (PBO)+dose-optimised MTX in inducing and sustaining …

Objectives This 52-week, randomised, double-blind phase IIIb study assessed efficacy and
safety of certolizumab pegol (CZP) as add-on therapy to non-biologic disease-modifying …

Introduction The rheumatoid arthritis-specific Work Productivity Survey (WPS-RA) measures
the impact of rheumatoid arthritis (RA) and treatment on patient productivity within and …

Objective To assess the impact of certolizumab pegol (CZP), a novel PEGylated anti–tumor
necrosis factor, in combination with methotrexate (MTX) on productivity outside and within …

Introduction The arthritis-specific Work Productivity Survey (WPS) was developed to evaluate
productivity limitations associated with arthritis within and outside the home. There is an …

Objectives. To evaluate the association between improvements in physical function, fatigue
and pain and improvements in productivity at work and at home in patients treated with …

Almost all tumors are composed of a heterogeneous cell population, making them difficult to
treat. A small cancer stem cell population with a low proliferation rate and a high …

Objectives To evaluate the effect of certolizumab pegol (CZP) on productivity outside and
within the home, and on participation in family, social and leisure activities in adult patients with …